Comparative Pharmacology
Head-to-head clinical analysis: CYCLOCORT versus FLUONID.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CYCLOCORT versus FLUONID.
CYCLOCORT vs FLUONID
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive actions. Suppresses cytokine production, inhibits phospholipase A2, and reduces prostaglandin synthesis.
Fluocinolone acetonide is a corticosteroid that binds to the glucocorticoid receptor, leading to inhibition of phospholipase A2, reduction of prostaglandin and leukotriene synthesis, and suppression of inflammatory mediators.
Apply a thin film topically to affected area twice daily (morning and evening). Not for ophthalmic use.
0.05% cream or ointment applied topically to affected area once daily. Not to exceed 30 g per week.
None Documented
None Documented
3.5 hours (terminal); clinical effect duration longer due to tissue binding.
3.5 hours; prolonged to 18–24 hours in severe hepatic impairment.
Primarily hepatic metabolism; inactive metabolites excreted renally (<1% unchanged) and in feces (biliary).
Renal 70% as unchanged drug, biliary/fecal 30% as metabolites.
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid